Eton Pharmaceuticals Inc.

ETON | NASDAQ

Price Alert Chart Builder DCF Calculator

$55.31

-$0.19 (-0.34%)

At close: Sep 21, 2026, 4:00 PM ET

$56

+$0.69 (+1.25%)

Pre-market: Sep 22, 2026, 8:18 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-4.6M	-3.82M	-936K	-9.02M	-1.96M	-27.97M
Depreciation & Amortization	4.04M	1.15M	901K	1.77M	462K	651K
Stock-Based Compensation	5.51M	3.17M	3.14M	4.22M	3.38M	2.58M
Other Working Capital	4.61M	1.41M	5.39M	4.06M	-910K	-320K
Other Non-Cash Items	6.43M	1.18M	184K	189K	148K	1.39M
Deferred Income Tax	n/a	n/a	n/a	n/a	-546K	n/a
Change in Working Capital	-859K	-698K	3.53M	7.66M	-6.21M	1.01M
Operating Cash Flow	10.52M	969K	6.82M	4.82M	-4.72M	-22.35M
Capital Expenditures	-333K	-26K	-775K	-2.79M	-3.26M	-50K
Cash Acquisitions	n/a	-30M	n/a	n/a	700K	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-9.99M	n/a	-2.75M	n/a	n/a
Investing Cash Flow	-333K	-40.01M	-775K	-2.79M	-2.56M	-50K
Debt Repayment	n/a	24.15M	-1.16M	-385K	-150K	2.48M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	217K	248K	198K	251K	n/a	367K
Financial Cash Flow	815K	32.59M	-957K	-134K	391K	31.63M
Net Cash Flow	11.01M	-6.45M	5.08M	1.9M	-6.89M	9.23M
Free Cash Flow	10.19M	943K	6.04M	2.03M	-7.98M	-22.4M
Adj. Free Cash Flow	4.68M	-2.22M	2.9M	-2.19M	-11.36M	-24.97M
Maintenance CapEx	n/a	n/a	-253.37K	-2.79M	-22.09K	-50K
Growth CapEx	-333K	-26K	-521.63K	n/a	-3.24M	n/a
Owner Earnings	10.52M	969K	6.56M	2.03M	-4.74M	-22.4M